Literature DB >> 9738633

Vascular and lipid syndromes in selected HIV-infected patients.

R SoRelle.   

Abstract

Entities:  

Mesh：

Year:  1998        PMID： 9738633     DOI： 10.1161/01.cir.98.9.829

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  7 in total

Review 1.  An Increase in Serum Creatinine after Initiation of Fenofibrate in an HIV-Infected Individual: A Case Report and Review of the Literature.

Authors:  Christine B Bruno; Jeffrey M Schapiro; Parya Saberi
Journal:  J Int Assoc Physicians AIDS Care (Chic)       Date:  2011-04-25

2.  Hospitalization due to adverse drug reactions and drug interactions before and after HAART.

Authors:  M M Foisy; K Gough; C M Quan; K Harris; D Ibanez; A Phillips
Journal:  Can J Infect Dis       Date:  2000-07

Review 3.  Lipodystrophy syndrome in HIV infection: what is it, what causes it and how can it be managed?

Authors:  G M Behrens; M Stoll; R E Schmidt
Journal:  Drug Saf       Date:  2000-07       Impact factor: 5.606

Review 4.  Metabolic complications associated with HIV protease inhibitor therapy.

Authors:  David Nolan
Journal:  Drugs       Date:  2003       Impact factor: 9.546

5.  Decreased heart rate variability in HIV positive patients receiving antiretroviral therapy: importance of blood glucose and cholesterol.

Authors:  Gro Askgaard; Ulrik Sloth Kristoffersen; Jesper Mehlsen; Gitte Kronborg; Andreas Kjaer; Anne-Mette Lebech
Journal:  PLoS One       Date:  2011-05-31       Impact factor: 3.240

6.  Epidemiology and management of antiretroviral-associated cardiovascular disease.

Authors:  Daniel B Chastain; Harold Henderson; Kayla R Stover
Journal:  Open AIDS J       Date:  2015-03-31

7.  Protease inhibitors and cardiac autonomic function in HIV-infected patients: a cross-sectional analysis from the Strategies for Management of Antiretroviral Therapy (SMART) Trial.

Authors:  Elsayed Z Soliman; Mollie P Roediger; Daniel A Duprez; Hernando Knobel; Richard Elion; James D Neaton
Journal:  BMJ Open       Date:  2013-03-06       Impact factor: 2.692
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.